Cancer Focus Fund is an oncology-focused venture capital firm established in collaboration with The University of Texas MD Anderson Cancer Center. It invests in promising cancer therapies at or near FDA Phase I or II clinical trials, financing clinical development alongside MD Anderson's research and trial expertise.
60% of their portfolio is in Biotech & Life Sciences. They made 1 investment in the last 12 months. Their most common stage is series-a (60% of deals). Average disclosed round size is $24.6M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$50M
Top Stage
Series A
Last 12 Mo
1
Team
Ross P. Barrett
Managing Partner
Jennifer P. Pou
Principal
Avery Green
Investor Relations Analyst
Will Ballard
Data Analytics Analyst
Jonathan Fassberg
Investment Committee
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Starget Pharma Inc | Series A | $18M | Feb 2026 |
| VVolnay | Series A | $28.4M | Jan 2024 |
| NNectin Therapeutics | Series A | — | Nov 2022 |
 KAHR | Unknown | $46.5M | Jun 2021 |
| NNectin Therapeutics | Series B | $5.4M | — |
Top Co-Investors
Last updated: 27 September 2026